Dementia drug linked to lethal bleeds will 'get the green light' in the US, swaying UK health chiefs to do the same, says expert

15 May 2023

"Once the FDA approve lecanemab, it will be up to the UK medical regulators to make their call. I trust that they will make the right decision," said Professor Robert Howard (UCL Psychiatry) who highlighted the possible life-threatening side effects for the new dementia drug.